Does vitamin D deficiency drive immune dysregulation, autoimmune thyroid disease, and cardiometabolic risk?

Vitamin D, primarily functioning through its active metabolite 1,25-dihydroxyvitamin D [1,25D], is an essential regulator of both the immune and metabolic systems. Deficiency in serum 25-hydroxyvitamin D [25(OH)D] is robustly associated with the loss of immune tolerance and a shift toward pro-inflammatory states.

Immune dysregulation and autoimmunity

Vitamin D deficiency is a primary driver of immune-mediated pathology through its failure to regulate the Vitamin D Receptor (VDR).

• Mechanistic pathways: Deficiency leads to the loss of inhibition of the NF-κB transcription factor, resulting in the overproduction of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-17. It also disrupts the T-helper cell balance by promoting the expansion of pro-inflammatory Th17 cells while reducing the population of regulatory T cells (Tregs).
• Autoimmune Thyroid Disease (AITD): Strong evidence links deficiency to Hashimoto's thyroiditis and Graves' disease. Meta-analyses show that individuals with AITD have significantly lower serum vitamin D levels (mean difference ~19 ng/mL) compared to controls. Correcting deficiency through supplementation has been shown to significantly reduce anti-thyroid peroxidase (TPOAb) and thyroglobulin (TGAb) antibody titers.

Cardiometabolic outcomes

The association between vitamin D and metabolic health is supported by observational data, though interventional evidence for a curative effect is less consistent.

• Insulin resistance: Serum 25(OH)D levels are inversely correlated with HOMA-IR, particularly in diabetic and overweight populations. Low levels are linked to impaired insulin secretion and sensitivity, potentially due to the presence of VDRs in pancreatic beta cells.
• Dyslipidemia: Deficiency is associated with elevated triglycerides, total cholesterol, and LDL-C, alongside reduced HDL-C. In postmenopausal women, while vitamin D may help reduce triglycerides, clinical trials have not consistently shown significant improvements in LDL-C or other lipid markers after supplementation.

Bottom line

Vitamin D deficiency is a critical factor in immune dysregulation and is strongly associated with an increased risk of autoimmune thyroid disease and metabolic markers like insulin resistance. While supplementation effectively reduces thyroid autoantibodies, its impact on reversing established dyslipidemia or insulin resistance is more variable and may depend on individual baseline levels and metabolic health.